Business Description
Annovis Bio is a Pennsylvania-based medical research company focused on developing treatments for brain diseases such as Alzheimer's, Parkinson's, and dementia. Its most advanced drug, Buntanetap, is currently being tested in late-stage clinical trials for both Alzheimer's and Parkinson's disease. The company also has two other drug candidates at various stages of testing, targeting traumatic brain injury, stroke, and cognitive decline. Founded in 2008, Annovis Bio continues to build a pipeline aimed at slowing or reversing the progression of neurological conditions.
